Technicals Stability Returns

Fundamental Analysis of Indoco Remedies (INDOCO)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Valuation Ratio    Profitability Ratios    Solvency    Efficiency Ratios    

Guru Numbers
Book Value/Share98.18
EV/EBITDA11.22
Market Cap (Cr)3087.04
Enterprise Value (Cr)3311.46
Piotroski F-Score8.00
Altman Z Score5.84
Graham No193.97
Price/ Graham 1.73
Peter Lynch Ratio3.37
Sloan Ratio0.069
Peter Lynch Fair value263.91
Price/ Peter Lynch FV1.27
TSR Fair value421.03
Key Financial ratios of INDOCO
Ratio Latest FY Yoy Change TTM MRQ Screener/
About
Price to Earning    22.44 -21.17 % 19.67    
Price to Book    3.84 11.48 % 3.06 3.19    
Price to Sales    2.26 3.71 % 1.89    
Earning Per Share    16.80 66.34 % 17.03 3.05    
Return On Equity    17.11 41.42 % 17.11 2.90    
Return On Asset    10.42 47.22 % 10.14 1.69    
Net Profit Margin    10.05 31.59 % 9.59 7.05    
Operating Profit Margin    16.12 24.76 % 15.07 11.24    
EBITDA Margin    21.40 15.29 % 18.58 15.63    
Debt to Equity Ratio    0.270 -20.08 % 0.297    
Current Ratio    1.82 19.03 % 1.67    
Quick Ratio    1.09 15.31 % 1.02    
View Historitcal ratios of Indoco Remedies
Valuation Ratios   Profitability Ratio   Solvency Ratios   Efficiency Ratios
Screen Financial Ratio using Custom Screener
Terrific View
Tsr Stability Index - Good Score of 75.00
Piotroski F Score - Excellent Value of 8.0
Altman Z Score of 5.84 suggests good Stability
Undervalued - Price to Intrinsic Value of 0.797
Debt to equity ratio has decreased and is lowest in last five years
Tremendous increasing trend in total sale last 3 year
Tremendous increasing in Book Value last 3 year
Company Earning excess return
Steady View
Annual Net Profit in last 3 years is trending up
Steady increase in Total Assets for last 3 Years
EBITDA is continuously increasing for last 3 Years
Company financial liquidity has improved
Good Return On Capital Employed of 13.47
Good Return on Equity of 17.11% is achieved by the company
Risky View
Tsr Growth Index - Poor Score of 27.79
Very Low Dividend Yield of 0.440 %
Low Earning Yield of 5.01 %
EPS decline for last four quarters
Terrific Steady Risky Stock View - Fundamental Snapshot
Share Overview
Promoter Owned58.70 %
Institution Owned19.10 %
Public/Others22.20 %
Outstanding Shares9.22 Cr
Floating Shares3.64 Cr
Floating / Outstanding39.46%
Book Value/Share98.18
Face value2.00
Share Holding
Annual Key Income Statement of INDOCO
Period 31_Mar_2022 31_Mar_2021 Growth
Net Income From Continuing Ops 154.80 93.05 66.36 %
Net Income 154.80 93.05 66.36 %
Operating Income 248.38 157.46 57.74 %
Total Revenue 1540.75 1218.61 26.44 %
Operating Expense 1255.35 701.51 78.95 %
Interest Expense 16.46 21.04 21.77 %
Tax Expense 81.77 38.95 109.94 %
Income Before tax 236.57 132.00 79.22 %
Gross Profit 1083.96 858.97 26.19 %
Dividend Paid -13.79 -2.79 394.27 %
   
Quarterly Key Income Statement of INDOCO
Period 31_Dec_2022 30_Sep_2022 Growth
Net Income From Continuing Ops 28.15 49.73 43.39 %
Net Income 28.14 49.73 43.41 %
Operating Income 44.87 87.85 48.92 %
Total Revenue 399.20 433.04 7.81 %
Operating Expense 337.16 345.19 2.33 %
Interest Expense 7.01 5.25 33.52 %
Tax Expense 10.07 17.57 42.69 %
Income Before tax 38.22 67.30 43.21 %
Gross Profit 268.85 305.65 12.04 %
Dividend Paid 0 -0.0400 100.00 %
   
Key Balance Sheet Fields
Period 31_Mar_2022 31-Mar-21 Growth
Common Stock 18.43 18.43 0 %
Current Liabilities 424.85 406.92 4.41 %
Total Liabilities 581.45 546.07 6.48 %
Current Assets 773.62 622.53 24.27 %
Total Assets 1486.09 1315.06 13.01 %
Working capital 348.77 215.61 61.76 %
Accounts Payable 133.29 113.23 17.72 %
Inventory 310.52 237.85 30.55 %
Net Receivable 298.68 235.39 26.89 %
   
Key Cash Flow Fields
Period 31_Mar_2022 31_Mar_2021 Growth
Cash EPS 22.32 18.03 23.79 %
Cash From Investment Activity -121.41 -66.69 82.05 %
Cash From Financial Activity -44.37 -29.87 48.54 %
Cash Operational Activity 173.83 82.22 111.42 %
Net Cash Flow 8.05 -14.34 156.14 %
NetIncome 154.80 93.05 66.36 %
Capital Expenditure 125.32 76.85 63.07 %
Change To Inventory -72.66 -29.53 146.05 %
   



   About Indoco Remedies Limited
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. The company's products portfolio includes respiratory products, such as Karvol Plus, Febrex Plus, Dropizin, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Sensodent-KF, Poviclean, Rexidin, Sensodent-R, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclopam Plus, Cyclomeff, and Nosic; pain/analgesics products that include Lignox A and Lignox ; and ophthal/otologicals products, such as Renolen, Homide, Dexoren " S, Zincoren, Bfloren, Dexoren, Otorex, Mofloren-D, Mofloren " BF, Macuchek, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Coloferrin, Cal Aid, and MCBM DHA; urology products, such as Cital-H and Cital; Cloben G, Noxa, and Scabex for dermatology; ATM, Clygan, Vepan, and Oxipod for anti-infectives; Hemsyl for blood related therapies; MCBM 69 and D-Chiro for gynecological; Aloja and Aloja M for Anti-Diabetics; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Address : Indoco House, Mumbai, India, 400098

URL : https://www.indoco.com

Employee Count : 6000

About TSR TECH Strength / Valuation / Growth

TSR Tech Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is calculate from 5Mins Ticck to One Month Tick

TSR Growth analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access Growth Potential

TSR Value analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access its value

This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.